Hepion Pharmaceuticals, Inc.

Biotech Red Bank, NJ

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Red Bank, NJ
Street
34 Shrewsbury Ave.
Zip
07701

Offering

Total offering
$700k
Amount sold
$700k
First sale
Apr 21, 2026
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
11

How this filing compares

Ranked #39 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 0.2× the median.

Other New Jersey filings this week: Darwin Investment Systems, Inc., DIASPO TECHNOLOGIES INC, Langan Management Aggregator LLC, Pranam Fund Limited Partnership, AUGUREY VENTURES II, LLC - SERIES ANDURIL B

Leadership

Gary Stetz — Executive Officer (also: Director)

Also named on: Canton Strategic Holdings, Inc.

Vincent LoPriore — Executive Officer (also: Director)

Also named on: Canton Strategic Holdings, Inc.

Sireesh Appajosyula — Director

Also named on: Canton Strategic Holdings, Inc.

Chase LoPriore — Director

Michael Purcell — Director

Timothy Block — Director

Filing details

Hepion Pharmaceuticals, Inc. filed a Form D with the SEC on April 22, 2026.

Other newest Biotech companies

Other newest companies in New Jersey